Site Search

Displaying results 711 - 720 of 893

Pierre Meulien named as new Executive Director of Innovative Medicines Initiative

News | 15/06/2015 |

Press releases

IMI2/OUT/2015-01652 Pierre Meulien brings to the post extensive experience of working in academia, industry, and research-funding organisations on both sides of the Atlantic. Dr Meulien comes to IMI from Genome Canada and will take up his duties in mid-September 2015. IMI is a ...

COMBACTE-MAGNET

Project| Ongoing | IMI1 |
Antimicrobial resistance
Infectious diseases
ND4BB
Clinical trial design
Conducting clinical trials
Clinical networks

Combatting bacterial resistance in Europe - molecules against Gram negative infections

46th Edition – May 2015

Newsletter Issue | May 2015

Table of contents:

EPAD

Project| Closed | IMI1 |
Neurodegenerative diseases
Alzheimer's disease
Clinical trial design
Conducting clinical trials

European prevention of Alzheimer’s dementia consortium

FLUCOP

Project| Closed | IMI1 |
Respiratory diseases
Infectious diseases
Vaccines

Standardization and development of assays for assessment of influenza vaccines correlates of protection

COMBACTE-CARE

Project| Ongoing | IMI1 |
Antimicrobial resistance
Infectious diseases
ND4BB
Clinical trial design
Conducting clinical trials

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

DRIVE-AB

Project| Closed | IMI1 |
Antimicrobial resistance
Infectious diseases
ND4BB
Methods for benefit/risk assessment

Driving re-investment in R&D and responsible antibiotic use

45th Edition – April 2015

Newsletter Issue | April 2015

Table of contents:

IMI response to European Parliament vote on 2013 discharge procedure

News | 29/04/2015 |

Press releases

Brussels, Belgium, 29 April 2015 - IMI is extremely pleased that the European Parliament has voted in favour of granting IMI discharge for 2013. Nevertheless, IMI takes the concerns raised during the debates seriously. Over the coming weeks, we will carefully review the comments ...

IMI and World Anti-Doping Agency to collaborate

News | 14/04/2015 |

Press releases

IMI2/OUT/2015-00283 Newly-signed Memorandum of Understanding (MoU) between IMI & World Anti-Doping Agency (WADA) formalises collaboration IMI and WADA to share knowledge and collaborate on areas of common interest Potential areas for collaboration include ageing, frailty, lung ...